PMC:7172841 / 1571-1659 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"T23","span":{"begin":46,"end":50},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":3,"end":5},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}

{"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":0,"end":88},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":68,"end":88},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T54","span":{"begin":3,"end":7},"obj":"PR:000001393"},{"id":"T55","span":{"begin":16,"end":27},"obj":"DG_35"},{"id":"T56","span":{"begin":46,"end":56},"obj":"SP_7"},{"id":"T57","span":{"begin":75,"end":88},"obj":"GO:0065007"},{"id":"T288","span":{"begin":3,"end":7},"obj":"PR:000001393"},{"id":"T45776","span":{"begin":16,"end":27},"obj":"DG_35"},{"id":"T71931","span":{"begin":46,"end":56},"obj":"SP_7"},{"id":"T97850","span":{"begin":75,"end":88},"obj":"GO:0065007"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}

{"project":"LitCovid-PubTator","denotations":[{"id":"85","span":{"begin":3,"end":7},"obj":"Gene"},{"id":"86","span":{"begin":46,"end":56},"obj":"Species"},{"id":"87","span":{"begin":16,"end":27},"obj":"Chemical"}],"attributes":[{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:3569"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"Tax:2697049"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation"}